|
|
Congress Alerts
|
Clinical Spotlight from the 2011 European Nephrology Congress in Prague
|
|
 |
|
25 June 2011
|
| |
|
This expert interview with Chantal Loirat, MD, from the Hospital Robert Debré in Paris, France, and Janice Galleshaw, MD, from prIME Oncology in Atlanta, Georgia, United States, along with an eNewsflash and downloadable slides, covers the topic of atypical hemolytic uremic syndrome (aHUS) focusing on the following data releases:
Abstract SuO005: Efficacy and safety of eculizumab in patients with atypical hemolytic uremic syndrome (aHUS) resistant to plasma exchange/infusion
Abstract Sa183: Efficacy and safety of eculizumab in patients with atypical hemolytic uremic syndrome (aHUS) receiving chronic plasma exchange/infusion: Interim analysis of a phase II study
Abstract Sa182: Efficacy and safety of eculizumab treatment for atypical hemolytic uremic syndrome (aHUS) in pediatric patients: Subgroup analysis of a retrospective study
|
| |
|
|
| |
|
 View the Expert Interview
View eNewsflash |
|
|
|
|
|
|
